01 · The Goal

Restore the lung function function lost to disease or injury

The goal is to restore lung function function that disease or injury has taken — restoring breathing capacity lost to chronic lung disease. This matters because of who is on the other side of it: people who would get their health, and their independence, back.

02 · Why It Matters

The lungs exchange the oxygen every cell needs, and damaged airways and scarred lung tissue — from COPD, fibrosis, and injury — leave millions short of breath, with little that reverses the loss. Protecting the lungs, regenerating airway and alveolar tissue, and restoring breathing capacity would transform chronic lung disease. Every breath depends on it — and for millions short of breath, restoring the lungs is restoring the freedom to live.

03 · What We’re Trying to Achieve

We are building the capability to restore lung function: rebuilding or replacing what is lost and combining repair with targeted rehabilitation. The work runs from proven clinical care now to the frontier science still maturing — and this page marks exactly where each piece stands.

04 · How It Works

How it works

Replacing what is lost Demonstrated in research

Cell and tissue therapies rebuild lost function in research and early studies.

Supporting function today Clinical

Established clinical treatments restore or support lost function now.

Full functional restoration Frontier

Restoring complete, durable function is an active laboratory frontier.

Pairing repair with rehabilitation Clinical

Combining tissue or cell repair with intensive, targeted rehabilitation drives the fullest functional recovery — established in practice.

05 · Who’s Building It

Cited as evidence the capability is real — not as partners or endorsers.

Government & programs

National Heart, Lung, and Blood Institute (NHLBI, NIH) · NIH lung-regeneration programs. These public programs fund the foundational research that shows the capability is real.

Universities & institutes

Academic pulmonary, lung-regeneration, and airway-biology research centers. Academic laboratories carry that science from discovery toward the clinic.

Enabling science base

lung stem cells · alveolar & airway biology · anti-fibrotic therapy · lung tissue engineering. — the established disciplines this capability is built upon.

06 · Technologies

The technologies: lung stem-cell and regeneration biology, anti-fibrotic therapies that slow scarring, airway-repair approaches, and protective measures against inhaled damage.

07 · Breakthroughs

Tissue repair Demonstrated

Cell and tissue therapies rebuild function in research.

Clinical support Clinical

Treatments restore function today.

Full restoration Frontier

Complete restoration is early-stage.

Clinical translation underway Clinical trials

Several restorative approaches have moved from the lab into human trials — the bridge from demonstrated biology to everyday care.

08 · Remaining Challenges

The honest challenges: partial restoration and support are within reach; complete, durable restoration is frontier. Clinical support exists today; deep regeneration is demonstrated-to-frontier. Getting new cells and tissue to survive, connect, and function durably in a living person — not just in a dish or an animal — is the central work, and it is exactly where the most careful, best-funded research is now aimed. We show where each piece stands, so the promise is never mistaken for the proof.

09 · Mature Capability

The future, fully built

Function that lung function lost to disease or injury is restored — tissue rebuilt, capability regained — so loss becomes recoverable. — staged plainly here, so the promise is always measured against the proof.

Honest boundary: each item is tagged for where it stands — demonstrated, clinical, or frontier. The science is real, funded, and accelerating. AI supports human clinicians; it never replaces them.
10 · Evidence Vault

The proof, for this capability

Cited as evidence the capability is real, not as partners or endorsers.

Tissue/cell therapy

Therapies rebuild function in research and early studies. Stage: Demonstrated.

Clinical support

Treatments restore function today. Stage: Clinical.

Full restoration

Complete durable restoration is early-stage. Stage: Frontier.

Honest framing

Real organizations are cited as evidence the capability is real — not as partners or endorsers. Support is clinical; full functional restoration in people is demonstrated-to-frontier and not claimed as routine.

Where it stands

Each line above is tagged for its stage — demonstrated, clinical, or frontier — so the page shows exactly how far the real science has come, and how far is left.

Help build this future

Every signature grows the movement to make lung-function restoration real — and free at the point of need.

Paid for by Michael Floyd for President.

Scroll to Top